Report Categories
View AllRecent Articles
View All
OVID Ovid Therapeutics swings to profit with 1181 revenue jump defying biotech sector headwinds in Q4 2025
Vanguard Financials Index Fund ETF VFH Q1 2026 Big Bank Earnings Outlook and NearTerm Upside Catalysts
SILO Silo Pharma reports widerthanexpected Q4 2023 loss shares dip 162 amid weak investor sentiment
DBCAW DBoral Warr warrants draw speculative interest as investors eye potential acquisition targets analysts monitor closely for strategic developments
Prudential Financial Preferred PRH Edges Lower Amid YieldDriven Correction
Australian Oilseeds Holdings Warrants COOTW Surge 105 but Remain Near AllTime Lows
Hercules Capital Notes HCXY Edge Higher Yield and Stability in Focus
enCore Energy Corp EU Edges Higher Amid Stabilizing Uranium Sentiment
DarkIris Inc DKI Gains 144 as Momentum Builds Toward Resistance